Jerry Hsu

Jerry Hsu is a seasoned medical professional with extensive experience in clinical development and oncology. Currently serving as Senior Vice President of Clinical Development at Arrivent Biopharma since June 2021, Jerry previously held the position of Group Medical Director in Product Development Oncology at Genentech from 2010 to June 2021, where responsibilities included both early and product development stages. Jerry's medical training includes a fellowship in medical oncology at Stanford University School of Medicine from 2006 to 2010 and an internal medicine residency at Duke University Hospital from 2004 to 2006. Academically, Jerry Hsu earned an M.D./Ph.D. in Medicine/Cancer Biology from Stanford University School of Medicine and a Bachelor of Arts in Biochemical Sciences from Harvard University.